title: Helicobacter pylori suppresses glycogen synthase kinase 3beta to promote beta-catenin activity.
abstract: The human pathogen Helicobacter pylori influences cell adhesion, proliferation, and apoptosis and is involved in gastric adenocarcinoma formation. In our study we analyzed the impact of H. pylori infection on the regulation of beta-catenin, which plays a central role in both cell adhesion and tumorigenesis. Infection of Madin-Darby canine kidney cells with H. pylori led to suppression of Ser/Thr phosphorylation and ubiquitin-dependent degradation of beta-catenin and to up-regulation of lymphoid enhancer-binding factor/T cell factor (LEF/TCF)-dependent transcription. The impaired Ser/Thr phosphorylation of beta-catenin was accompanied by an increase of glycogen synthase kinase 3beta phosphorylation. Inhibition of Akt kinase, an up-stream regulator of glycogen synthase kinase 3, by a specific inhibitor Akti-1/2 or depletion of Akt with siRNA restored Ser/Thr phosphorylation of beta-catenin. We conclude that glycogen synthase kinase 3beta activity exerts an important role in beta-catenin regulation and LEF/TCF transactivation in H. pylori-infected Madin-Darby canine kidney cells.
authors.affiliation: Institute of Experimental Internal Medicine, Otto von Guericke University, Magdeburg 39120, Germany.
authors.forename: Olga
authors.initials: O
authors.lastname: Sokolova
authors.forename: Przemyslaw M
authors.initials: PM
authors.lastname: Bozko
authors.forename: Michael
authors.initials: M
authors.lastname: Naumann
mesh_terms: D000818:Animals; D002460:Cell Line; D019938:Cyclin D1 / Q000096:biosynthesis; D004285:Dogs; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism*; D000071679:Glycogen Synthase Kinase 3 beta; D016481:Helicobacter Infections / Q000175:diagnosis / Q000378:metabolism; D016480:Helicobacter pylori / Q000378:metabolism*; D051821:Lymphoid Enhancer-Binding Factor 1 / Q000378:metabolism; D008954:Models, Biological; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D034741:RNA, Small Interfering / Q000378:metabolism; D015533:Transcriptional Activation; D015854:Up-Regulation; D051176:beta Catenin / Q000378:metabolism*
chemical_list: D051821:Lymphoid Enhancer-Binding Factor 1; D034741:RNA, Small Interfering; D051176:beta Catenin; D019938:Cyclin D1; C000605506:GSK3B protein, human; D000071679:Glycogen Synthase Kinase 3 beta; D051057:Proto-Oncogene Proteins c-akt; D038362:Glycogen Synthase Kinase 3
references.citation: J Cell Sci. 2008 Jun 1;121(11):1793-802
references.pmid: 18460581
references.citation: J Biol Chem. 2001 Oct 5;276(40):37436-42
references.pmid: 11495916
references.citation: Int J Med Microbiol. 2005 Sep;295(5):335-41
references.pmid: 16173500
references.citation: Oncogene. 1999 Jan 28;18(4):849-54
references.pmid: 10023660
references.citation: Gut. 2006 Jun;55(6):775-81
references.pmid: 16322107
references.citation: Gene. 2004 Oct 27;341:1-17
references.pmid: 15474284
references.citation: Science. 2004 Mar 5;303(5663):1483-7
references.pmid: 15001769
references.citation: Cell. 2001 May 4;105(3):391-402
references.pmid: 11348595
references.citation: Int J Oncol. 2001 Sep;19(3):533-6
references.pmid: 11494032
references.citation: Dev Dyn. 2002 May;224(1):18-29
references.pmid: 11984870
references.citation: Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10646-51
references.pmid: 16027366
references.citation: Mol Pathol. 2003 Feb;56(1):19-24
references.pmid: 12560457
references.citation: J Cell Sci. 2003 Apr 1;116(Pt 7):1175-86
references.pmid: 12615961
references.citation: Int J Surg Pathol. 2003 Jan;11(1):1-9
references.pmid: 12598910
references.citation: Genes Cells. 1999 Dec;4(12):757-67
references.pmid: 10620020
references.citation: J Biol Chem. 1997 Oct 3;272(40):24735-8
references.pmid: 9312064
references.citation: J Cell Biol. 2004 Oct 25;167(2):339-49
references.pmid: 15492040
references.citation: J Exp Clin Cancer Res. 2005 Sep;24(3):337-45
references.pmid: 16270519
references.citation: Curr Biol. 1996 Dec 1;6(12):1664-8
references.pmid: 8994831
references.citation: Mol Cell Biol. 2006 Jan;26(1):261-76
references.pmid: 16354697
references.citation: Aliment Pharmacol Ther. 2002 Apr;16 Suppl 2:145-57
references.pmid: 11966535
references.citation: Cell Microbiol. 2004 Dec;6(12):1153-66
references.pmid: 15527495
references.citation: Biochem Biophys Res Commun. 2002 Jul 19;295(3):695-701
references.pmid: 12099696
references.citation: Ann N Y Acad Sci. 2000 Jun;910:21-33; discussion 33-5
references.pmid: 10911903
references.citation: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5522-7
references.pmid: 10318916
references.citation: Science. 2000 Mar 3;287(5458):1606-9
references.pmid: 10733430
references.citation: Mol Cell Biol. 2002 Jan;22(2):578-86
references.pmid: 11756553
references.citation: Neoplasma. 2002;49(2):95-100
references.pmid: 12088113
references.citation: EMBO J. 1997 Jul 1;16(13):3797-804
references.pmid: 9233789
references.citation: Oncogene. 2007 Jul 12;26(32):4617-26
references.pmid: 17237808
references.citation: Endocr Relat Cancer. 2003 Dec;10(4):537-60
references.pmid: 14713266
references.citation: World J Gastroenterol. 2005 Jul 28;11(28):4400-3
references.pmid: 16038041
references.citation: Hum Pathol. 2005 Dec;36(12):1294-301
references.pmid: 16311123
references.citation: Biochem Biophys Res Commun. 2004 Apr 16;316(4):1065-72
references.pmid: 15044093
references.citation: J Surg Oncol. 2005 Jun 1;90(3):114-33; discussion 133
references.pmid: 15895459
references.citation: Jpn J Cancer Res. 2002 Nov;93(11):1213-20
references.pmid: 12460462
references.citation: Oncology. 2001;60(4):339-45
references.pmid: 11408802
references.citation: J Cell Sci. 2002 Jul 1;115(Pt 13):2771-80
references.pmid: 12077367
references.citation: Science. 1996 May 17;272(5264):1023-6
references.pmid: 8638126
references.citation: Cell. 2002 Mar 22;108(6):837-47
references.pmid: 11955436
references.citation: Cells Tissues Organs. 2005;179(1-2):56-65
references.pmid: 15942193
references.citation: Mol Microbiol. 1994 Apr;12(2):307-19
references.pmid: 8057855
references.citation: Cancer Biol Ther. 2002 May-Jun;1(3):226-31
references.pmid: 12432268
references.citation: Adv Cancer Res. 2000;77:1-24
references.pmid: 10549354
references.citation: J Cell Biol. 2003 Apr 28;161(2):249-55
references.pmid: 12719469
references.citation: Curr Opin Cell Biol. 2005 Oct;17(5):499-508
references.pmid: 16107313
references.citation: Cancer Res. 2008 Jan 15;68(2):379-87
references.pmid: 18199531
references.citation: Biochem J. 2005 Jan 15;385(Pt 2):399-408
references.pmid: 15456405
references.citation: J Exp Med. 2005 Nov 7;202(9):1235-47
references.pmid: 16275761
references.citation: Exp Cell Res. 2007 Oct 1;313(16):3459-71
references.pmid: 17692843
references.citation: Int J Cancer. 2008 Feb 15;122(4):823-31
references.pmid: 17960618
references.citation: Pathology. 2004 Apr;36(2):120-8
references.pmid: 15203747
references.citation: Pathol Int. 2000 Oct;50(10):767-77
references.pmid: 11107048
references.citation: Curr Biol. 1999 Feb 25;9(4):207-10
references.pmid: 10074433
references.citation: Nature. 1995 Dec 21-28;378(6559):785-9
references.pmid: 8524413
references.citation: EMBO Rep. 2002 Jan;3(1):63-8
references.pmid: 11751573
references.citation: FEMS Microbiol Rev. 2006 Jan;30(1):131-56
references.pmid: 16438683
references.citation: FASEB J. 2002 Mar;16(3):417-9
references.pmid: 11790728
references.citation: Trends Microbiol. 2004 Jan;12(1):29-36
references.pmid: 14700549
references.citation: J Clin Pathol. 2006 Dec;59(12):1261-6
references.pmid: 16679349